Sartorius Stedim Biotech Aktie
207,90
EUR
+2,50
EUR
+1,22
%
209,50
EUR
+1,40
EUR
+0,67
%
Werbung
Sartorius Stedim Biotech Aktie Analyse
| 10.10.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
| 08.07.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
| 06.06.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
| 16.04.25 | Sartorius Stedim Biotech Market-Perform | Bernstein Research | |
| 29.01.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
| 24.01.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
| 22.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
| 03.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
|
Werbung
|
|||
| 27.06.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
| 23.04.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
| 11.08.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
| 18.04.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
Werbung
Werbung